醫藥品·生物科技的製造·供給契約(2020年～2025年)

"製藥與生物技術製造與供應合約" 深入分析了企業簽訂製造和供應協議的方式和原因。

這份經過全面修訂和更新的報告提供了2019年至2025年製造和供應協議的詳細資訊。

本報告提供了雙方宣布的製造和供應協議的付款條款。這些數據有助於深入了解付款條款和交易的其他條款。

了解潛在合作夥伴談判條款的彈性，可以為談判過程提供重要的參考，從而了解條款談判中可能出現的情況。許多中小企業尋求詳細的付款條款，但在付款方式和權利轉讓方面，關注細節至關重要。

本報告提供了自2020年以來已宣布的製造和供應協議的完整列表，這些協議均記錄在“當前協議”交易和聯盟數據庫中，包括可用的財務條款，以及公司及其合作夥伴向美國證券交易委員會提交的實際製造和供應協議文件的在線副本鏈接。

本報告的第一章提供了製造和供應協議及業務活動的指南。

第一章是對報告的介紹。第二章概述並分析了製造和供應趨勢，並討論了各種合約類型的優勢。

第三章概述了製造和供應協議的結構。

第四章回顧了自2020年以來的主要製造和供應交易。交易按標題價格列出。對於涉及美國證券交易委員會 (SEC) 揭露協議的交易，可透過 "當前協議" 協議和聯盟資料庫的連結在線存取這些協議。

第五章提供了25家最活躍的生產和供應合約製造商的完整清單。每個合約標題都透過 "當前協議" 合作夥伴交易資料庫連結到合約記錄的全文線上版本，並在可用時連結到實際合約文件，方便用戶按需存取每個合約記錄。

第六章全面深入地回顧了自2020年以來已達成和宣布的生產和供應合同，並按公司A-Z、療法、技術和行業（如有合同文件）進行組織。合約文件詳細介紹了雙方就生產和供應合約達成的實際條款。

合約目錄包含自2019年以來宣布的所有生產和供應合約的完整清單。每個清單都按公司A-Z、療法領域和技術類型組織成一個合約目錄。每個合約標題都透過超連結連結到合約記錄的線上版本，包括可用的實際合約文件。

本報告還包含大量圖表，展示了 2020 年及以後製造和供應合約的趨勢和活動。

總而言之，本報告提供了潛在合約製造商需要了解的有關製造和供應聯盟的所有資訊。

主要優勢

製藥和生物技術行業的製造和供應協議為讀者提供以下主要優勢：

• 了解 2020 年及以後的交易趨勢
• 瀏覽製造和供應交易
• 基準分析 - 確定交易市場價值
• 財務條款
• 按公司 A-Z、治療領域和技術類型排列的合約目錄
• 主要交易價值
• 最活躍的合約製造商
• 確定每筆交易的資產和交易條款
• 存取合約文件 - 深入了解合約結構
• 盡職調查 - 評估擬議交易條款是否適合您的合作夥伴
• 節省數百小時的研究時間

範圍

• 本報告旨在詳細了解主要製造和供應趨勢及交易結構全球生物製藥公司。

製藥和生物技術製造與供應協議包括：

• 生物製藥產業製造與供應合約趨勢
• 製造與供應合約結構概述
• 涵蓋製藥和生物技術的製造與供應合約記錄目錄
• 主要製造與供應合約
• 最活躍的製造與供應合約製造商
• 主要製造與供應合作夥伴訊息

"製藥和生物技術製造與供應合約" 列出了可用的合約。

• 公司 A-Z
• 標題價格
• 治療領域
• 技術類型
• 每個合約標題都透過網頁連結連結到實際的線上合約記錄，方便存取每個合約文件。
• "製藥和生物技術生產與供應合約" 提供對生產和供應合約記錄（包括現有合約文件）的全面存取。

分析合約文件可以對以下內容進行盡職調查：

• 授予或選擇哪些權利？
• 合約授予了哪些權利？
• 授予了哪些獨家經營權？
• 合約的付款結構是怎樣的？
• 如何審計銷售和付款？
• 合約期限是怎樣的？
• 合約的關鍵條款是如何定義的？
• 如何處理並擁有知識產權？
• 誰負責商業化？
• 誰負責開發、供應和生產？
• 如何管理保密和揭露問題？
• 爭議：如何解決爭議？
• 在什麼情況下可以終止合約？
• 如果所有權發生變更會怎樣？
• 雙方約定了哪些分授權或分包條款？
• 公司需要哪些標準條款？
• 哪些標準條款似乎會因合作夥伴或交易類型的不同而有所差異？
• 公司主張哪個契約法管轄區？

目錄

摘要整理

第1章 簡介

第2章 製造業和供給業的交易趨勢

• 簡介
• 製造及供給契約定義
• 2020年以後的製造·供給契約趨勢
  • 製造·供給契約的各年度轉變，2020年～2025年
  • 製造·供給契約，各開發階段，2020年～2025年
  • 製造·供給契約，各產業部門，2020年～2025年
  • 製造·供給契約，各治療領域，2020年～2025年
  • 製造·供給契約，各技術類型，2020年～2025年
  • 製造·供給契約，各企業，2020年～2025年
• 簽訂製造·供給聯盟契約的理由
• 製造和供給契約的未來

第3章 製造及供給契約結構概要

• 簡介
• 製造及供給契約結構

第4章 -主要製造及供給契約

• 簡介
• 各金額首位製造·供給契約

第5章 - 最活躍的製造·供給契約廠商主要25公司

• 簡介
• 最活躍的製造·供給契約廠商前幾名25公司

包含第6章 -契約名錄的製造及供給契約

• 簡介
• 按從2020年到2025年的契約製造及供給契約
• 交易名錄
• 交易名錄- 各企業製造·供給契約(AZ)
• 交易名錄- 各治療領域的製造及供給契約
• 交易名錄- 科技各類型的製造及供給契約
• 調查關於公司
• 目前聯盟
• 目前契約
• Current Partnering的最近的報告標題

Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology provides a detailed understanding and analysis of how and why companies enter manufacturing and supply deals.

Fully revised and updated, the report provides details of manufacturing and supply deals from 2019 to 2025.

The report provides access to manufacturing and supply deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of manufacturing and supply deals announced since 2020 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual manufacturing and supply contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of manufacturing and supply dealmaking and business activities.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview and analysis of the trends in manufacturing and supply as well as a discussion on the merits of the type of deal.

Chapter 3 provides an overview of the structure of manufacturing and supply deals.

Chapter 4 provides a review of the leading manufacturing and supply deals since 2020. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.

Chapter 5 provides a comprehensive listing of the top 25 most active manufacturing and supply dealmaker companies. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand.

Chapter 6 provides a comprehensive and detailed review of manufacturing and supply deals organized by company A-Z, therapy, technology and industry type signed and announced since 2020 where a contract document is available. Contract documents provide an indepth insight into the actual deal terms agreed between the parties with respect to the manufacturing and supply deal.

The deal directory includes a comprehensive listing of all manufacturing and supply deals announced since 2019. Each listing is organized as a deal directory by company A-Z, therapeutic area and technology type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.

The report also includes numerous table and figures that illustrate the trends and activities in manufacturing and supply dealmaking since 2020.

In conclusion, this report provides everything a prospective dealmaker needs to know about manufacturing and supply alliances.

Key benefits

Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology provides the reader with the following key benefits:

• Understand deal trends since 2020
• Browse manufacturing and supply deals
• Benchmark analysis - identify market value of transactions
• Financials terms
• Directory of deals by company A-Z, therapy focus and technology type
• Leading deals by value
• Most active dealmakers
• Identify assets and deal terms for each transaction
• Access contract documents - insights into deal structures
• Due diligence - assess suitability of your proposed deal terms for partner companies
• Save hundreds of hours of research time

Report scope

• Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology is intended to provide the reader with an in-depth understanding of the manufacturing and supply trends and structure of deals entered into by leading biopharma companies worldwide.

Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology includes:

• Trends in manufacturing and supply dealmaking in the biopharma industry
• Overview of manufacturing and supply deal structure
• Directory of manufacturing and supply deal records covering pharmaceutical and biotechnology
• The leading manufacturing and supply deals by value
• Most active manufacturing and supply dealmakers
• The leading manufacturing and supply partnering resources

In Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology, the available deals are listed by:

• Company A-Z
• Headline value
• Therapeutic area
• Technology type
• Each deal title links via Weblink to an online version of the actual deal record, providing easy access to each contract document where available.
• Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology provides comprehensive access to available records for manufacturing and supply deals, including contract documents where available.

Analyzing contract agreements allows due diligence of:

• What are the rights granted or optioned?
• What rights are granted by the agreement?
• What exclusivity is granted?
• What is the payment structure for the deal?
• How are sales and payments audited?
• What is the deal term?
• How are the key terms of the agreement defined?
• How are intellectual property rights handled and owned?
• Who is responsible for commercialization?
• Who is responsible for development, supply, and manufacture?
• How is confidentiality and publication managed?
• How are disputes resolved?
• Under what conditions can the deal be terminated?
• What happens when there is a change of ownership?
• What sublicensing and subcontracting provisions have been agreed?
• Which boilerplate clauses does the company insist upon?
• Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
• Which jurisdiction does the company insist upon for agreement law?

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in manufacturing and supply dealmaking

• 2.1. Introduction
• 2.2. Definition of manufacturing and supply deal
• 2.3. Trends in manufacturing and supply deals since 2020
  • 2.3.1. Manufacturing and supply dealmaking by year, 2020-2025
  • 2.3.2. manufacturing and supply dealmaking by phase of development, 2020-2025
  • 2.3.3. Manufacturing and supply dealmaking by industry sector, 2020-2025
  • 2.3.4. Manufacturing and supply dealmaking by therapy area, 2020-2025
  • 2.3.5. Manufacturing and supply dealmaking by technology type, 2020-2025
  • 2.3.6. Manufacturing and supply dealmaking by most active company, 2020-2025
• 2.4. Reasons for entering into manufacturing and supply partnering deals
• 2.5. The future of manufacturing and supply deals

Chapter 3 - Overview of manufacturing and supply deal structure

• 3.1. Introduction
• 3.2. manufacturing and supply agreement structure

Chapter 4 - Leading manufacturing and supply deals

• 4.1. Introduction
• 4.2. Top manufacturing and supply deals by value

Chapter 5 - Top 25 most active manufacturing and supply dealmakers

• 5.1. Introduction
• 5.2. Top 25 most active manufacturing and supply dealmakers

Chapter 6 - manufacturing and supply deals including contracts directory

• 6.1. Introduction
• 6.2. manufacturing and supply deals with contracts 2020-2025
• Deal directory
• Deal directory - manufacturing and supply dealmaking by companies A-Z
• Deal directory - manufacturing and supply dealmaking by therapy area
• Deal directory - manufacturing and supply dealmaking by technology type
• About Biopharma Research
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

TABLE OF FIGURES

• Figure 1: Definition of manufacturing and supply
• Figure 2: Trends in manufacturing and supply deal announcements, 2020-2025
• Figure 3: Manufacturing and supply deals signed at each phase of development, 2020-2025
• Figure 4: Manufacturing and supply deals by industry sector, 2020-2025
• Figure 5: Manufacturing and supply deals by therapy area, 2020-2025
• Figure 6: Manufacturing and supply deals by technology type, 2020-2025
• Figure 7: Top 25 most active manufacturing and supply dealmakers, 2020-2025
• Figure 8: Top manufacturing and supply deals by value, 2020-2025
• Figure 9: Most active manufacturing and supply dealmakers, 2020-2025